The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say made insulin prices soar.
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
The agency says the companies artificially inflated insulin list prices that resulted in patients paying more for the medications. The companies are CVS Health’s Caremark RX, Cigna’s Express Scripts, ...
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.
Scripps News on MSN1d
FTC sues pharmaceutical middlemen, claiming practices inflated insulin costThe Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...
The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...
Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback